10 X Genomics Inc (TXG)

Feb 22, 2025

Harvard, 10x Genomics Settle Patent Dispute With Vizgen - Harvard Crimson

Feb 22, 2025

Feb 21, 2025

10x Genomics, Inc. (NASDAQ:TXG) Stock's 28% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St

Feb 21, 2025

Feb 21, 2025

Alberta Investment Management Corp Makes New $3.21 Million Investment in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Feb 21, 2025

Feb 19, 2025

10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference - The Eastern Progress Online

Feb 19, 2025

Feb 19, 2025

10x Genomics, Inc. (NASDAQ:TXG) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Feb 19, 2025

Feb 19, 2025

Q1 EPS Estimates for 10x Genomics Lowered by Leerink Partnrs - MarketBeat

Feb 19, 2025

Feb 18, 2025

10x Genomics (NASDAQ:TXG) Lowered to "Hold" Rating by Leerink Partnrs - MarketBeat

Feb 18, 2025

Feb 18, 2025

10x Genomics (NASDAQ:TXG) Shares Up 8.3%Still a Buy? - MarketBeat

Feb 18, 2025

Feb 17, 2025

Citigroup Has Lowered Expectations for 10x Genomics (NASDAQ:TXG) Stock Price - MarketBeat

Feb 17, 2025

Feb 17, 2025

10x Genomics (NASDAQ:TXG) Price Target Cut to $12.00 by Analysts at JPMorgan Chase & Co. - MarketBeat

Feb 17, 2025

Feb 17, 2025

10x Genomics' SWOT analysis: genomics firm faces NIH funding headwinds - Investing.com

Feb 17, 2025

Feb 17, 2025

10x Genomics (NASDAQ:TXG) Shares Gap Down on Disappointing Earnings - MarketBeat

Feb 17, 2025

Feb 17, 2025

Leerink Partners Downgrades 10x Genomics (NASDAQ:TXG) to Market Perform - MarketBeat

Feb 17, 2025

Feb 16, 2025

10x Genomics (NASDAQ:TXG) Posts Earnings Results, Misses Expectations By $0.08 EPS - MarketBeat

Feb 16, 2025

Feb 16, 2025

Entropy Technologies LP Purchases 27,844 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Feb 16, 2025

Feb 15, 2025

10x Genomics (NASDAQ:TXG) Price Target Cut to $26.00 by Analysts at Morgan Stanley - MarketBeat

Feb 15, 2025

Feb 15, 2025

Leerink Partnrs Forecasts 10x Genomics Q1 Earnings - MarketBeat

Feb 15, 2025

Feb 15, 2025

Barclays Issues Pessimistic Forecast for 10x Genomics (NASDAQ:TXG) Stock Price - MarketBeat

Feb 15, 2025

Feb 14, 2025

Canaccord Genuity Group Has Lowered Expectations for 10x Genomics (NASDAQ:TXG) Stock Price - MarketBeat

Feb 14, 2025

Feb 14, 2025

UBS Group Cuts 10x Genomics (NASDAQ:TXG) Price Target to $14.00 - MarketBeat

Feb 14, 2025

Feb 14, 2025

10x Genomics falls on quarterly EPS miss, 2025 revenue guidance concern - MSN

Feb 14, 2025

Feb 14, 2025

Morgan Stanley Trims Price Target on 10x Genomics to $26 From $28, Keeps Overweight Rating - Marketscreener.com

Feb 14, 2025

Feb 14, 2025

10x Genomics Inc Reports Q4 Revenue of $165M, Beating Estimates; EPS of -$0.40 Misses Expectations - GuruFocus.com

Feb 14, 2025

Feb 14, 2025

Sumitomo Mitsui Trust Group Inc. Has $82.05 Million Stock Position in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Feb 14, 2025

Feb 13, 2025

10X Genomics Earnings Call: Innovations Amidst Revenue Challenges - TipRanks

Feb 13, 2025

Feb 13, 2025

10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025 - Victoria Advocate

Feb 13, 2025

Feb 13, 2025

Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties - Benzinga

Feb 13, 2025

Feb 13, 2025

10X Genomics stock plunges to 52-week low of $11.89 - MSN

Feb 13, 2025

Feb 13, 2025

10x Genomics, Inc. Provides Earnings Guidance for the Year 2025 -February 12, 2025 at 04:05 pm EST - Marketscreener.com

Feb 13, 2025

Feb 13, 2025

10x Genomics, Inc. (NASDAQ:TXG) Q4 2024 Earnings Call Transcript - MSN

Feb 13, 2025

Feb 13, 2025

UBS Adjusts Price Target on 10x Genomics to $14 From $20, Keeps Neutral Rating -February 13, 2025 at 10:09 am EST - Marketscreener.com

Feb 13, 2025

Feb 13, 2025

10x Genomics (NASDAQ:TXG) Reaches New 12-Month Low Following Analyst Downgrade - MarketBeat

Feb 13, 2025

Feb 13, 2025

10x Genomics Shares Tumble on Fear Over Cuts to NIH - Barron's

Feb 13, 2025

Feb 13, 2025

Leerink Partners Downgrades 10x Genomics to Market Perform From Outperform, Adjusts Price Target to $12 From $25 - Marketscreener.com

Feb 13, 2025

Feb 13, 2025

10x Genomics, Inc. SEC 10-K Report - TradingView

Feb 13, 2025

Feb 13, 2025

10x Genomics revenue increases 10% to USD 165M in Q4 2024 - Medical Buyer

Feb 13, 2025

Feb 13, 2025

10x Genomics Inc (TXG) Q4 2024 Earnings Call Highlights: Navigat - GuruFocus.com

Feb 13, 2025

Feb 13, 2025

Barclays Cuts 10x Genomics (NASDAQ:TXG) Price Target to $18.00 - MarketBeat

Feb 13, 2025

Feb 13, 2025

10x Genomics Inc (TXG) Q4 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance

Feb 13, 2025

Feb 12, 2025

10x Genomics: Q4 Earnings Snapshot - CT Insider

Feb 12, 2025

Feb 12, 2025

10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025 - BioSpace

Feb 12, 2025

Feb 12, 2025

Here's What Key Metrics Tell Us About 10x Genomics (TXG) Q4 Earnings - Yahoo Finance

Feb 12, 2025

Feb 12, 2025

Earnings call transcript: 10X Genomics Q4 2024 misses EPS forecast, stock dips - Investing.com

Feb 12, 2025

Feb 12, 2025

10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Feb 12, 2025

Feb 12, 2025

10x Genomics: Q4 Earnings Snapshot -February 12, 2025 at 04:54 pm EST - Marketscreener.com

Feb 12, 2025

Feb 12, 2025

10x Genomics (NASDAQ:TXG) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations - Yahoo Finance

Feb 12, 2025